Amarantus Bioscience Holdings Inc (AMBS)

[PENNYS ToMILLIONS]

I guess I wasn't clear....I was just giving an example ...MANF is has proven itself to be SUPERIOR to a product which large biotech Co's have spent 400 million on
Company had previously been unable to point to a definitive behavioural animal model data to show improved benefit of MANF over GDNF in the Parkinson's disease indication. The data we now have validates the approach we have been taking over the last several years, and we believe that it will allow us to attract the interest of investment firms and potential partners who will be able to now characterize the substantial opportunity our technology represents